These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23221058)

  • 1. [A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil].
    Ito T; Okubo K; Shiomi M; Narita M; Morita K; Takeuchi A; Kanazawa H; Shimizu J; Takeyama T; Hashizume K; Shibahara H; Nishimura D; Katada N; Katano Y; Goto H
    Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2088-96. PubMed ID: 23221058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
    Ishikawa T; Ichida T; Ishimoto Y; Yokoyama J; Nomoto M; Ebe Y; Usuda H; Naito M; Asakura H
    Am J Gastroenterol; 1999 Jun; 94(6):1682-5. PubMed ID: 10364045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose cisplatin plus oral tegafur and uracil for the treatment of lung metastases of hepatocellular carcinoma.
    Maeda T; Itasaka H; Takenaka K; Matsumata T; Shimada M; Ikeda T; Sugimachi K
    Hepatogastroenterology; 2003; 50(53):1583-6. PubMed ID: 14571791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].
    Tanabe K; Taura K; Hatano E; Koyama Y; Takada Y; Uemoto S
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1077-80. PubMed ID: 23986055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
    Hsu CY; Shen YC; Yu CW; Hsu C; Hu FC; Hsu CH; Chen BB; Wei SY; Cheng AL; Shih TT
    J Hepatol; 2011 Oct; 55(4):858-65. PubMed ID: 21338641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
    Miyamoto A; Umeshita K; Sakon M; Nagano H; Eguchi H; Kishimoto S; Dono K; Nakamori S; Gotoh M; Monden M
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1447-51. PubMed ID: 11197059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.
    Zavaglia C; Prisco C; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):87-8. PubMed ID: 18090998
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
    Hsu CH; Shen YC; Lin ZZ; Chen PJ; Shao YY; Ding YH; Hsu C; Cheng AL
    J Hepatol; 2010 Jul; 53(1):126-31. PubMed ID: 20416968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
    Miyano M; Kurai O; Hiramatsu S; Yamasaki T; Sasaki E; Adachi K; Oka H
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):1139-43. PubMed ID: 20567124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
    Suzuki E; Furuse J; Ikeda M; Ishii H; Okusaka T; Nakachi K; Mitsunaga S; Ueno H; Morizane C
    Jpn J Clin Oncol; 2011 Mar; 41(3):328-33. PubMed ID: 21118849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.
    Ishikawa T
    World J Gastroenterol; 2008 May; 14(18):2797-801. PubMed ID: 18473401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case report of chemotherapeutic control of a gastric cancer producing granulocyte-colony stimulating factor].
    Miyamoto M; Misawa S
    Nihon Shokakibyo Gakkai Zasshi; 2014 Apr; 111(4):748-55. PubMed ID: 24769464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of giant hepatocellular carcinoma effectively treated with UFT].
    Kazumori H; Sizuku T; Uchida Y; Moritani M; Yamamoto S
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1213-6. PubMed ID: 9679585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dissemination of hepatocellular carcinoma treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil.
    Miyake Y; Iwasaki Y; Shiraha H; Sakaguchi K; Shiratori Y
    Intern Med; 2007; 46(9):565-9. PubMed ID: 17473490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
    Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
    Inada M; Minami Y; Kawata S; Miyoshi S; Imai Y; Saito R; Noda S; Tamura S; Inui Y; Matsuda Y
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):531-5. PubMed ID: 3028279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
    Di Meglio G; Fazio N; Nolè F; Della Vigna P; Lorizzo K; Goldhirsch A; Farris A
    Acta Oncol; 2007; 46(8):1205-6. PubMed ID: 17978934
    [No Abstract]   [Full Text] [Related]  

  • 18. [A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective].
    Imamura Y; Baba Y; Tahara K; Kubozono O; Ogura Y; Maenohara S; Moriya H
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1981-3. PubMed ID: 12465400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
    Enomoto H; Ishii A; Imanishi H; Saito M; Tanaka H; Iwata Y; Sakai Y; Iwai T; Yoh K; Takashima T; Yoshikawa S; Aizawa N; Yamamoto T; Ikeda N; Shimomura S; Iijima H; Hirota S; Nishiguchi S
    Gan To Kagaku Ryoho; 2010 May; 37(5):919-22. PubMed ID: 20495329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.